Is telehealth solving health disparities for vulnerable populations?
The pandemic has forced HCPs to rethink care delivery, dramatically expanding…
Unconventional Trial Designs explained in 5 minutes
As the pharmaceutical industry evolves, a rising trend appears in clinical…
Managed Entry Agreements: The confidentiality issue
Managed Entry Agreements (MEAs) are contracts between pharmaceutical companies/…
Biosimilars: Enhancing physician uptake in the EU
At the moment, EU physicians seem much more comfortable than their US…
Challenges in the rare diseases' space
Rare diseases are a large group of diseases that affect a very small percentage…
Should we trust vaccines or not?
The first COVID-19 vaccines have been administered in several countries around…
Enhancing participant diversity in clinical trials
Clinical trials are carefully designed research studies that evaluate the…
Implementing Digital the right way
In the last few years, pharma has been very loud about the ways it is going to…
Lessons learned by Pharma during the pandemic
From cities under lockdown to the most affected areas, the coronavirus pandemic…
Patient centricity and how to achieve it
Patient centricity is the act of designing a service or solution around…
Privacy concerns in a digital healthcare space
In the era of social media platforms and AI technology, digital healthcare is…